Skip to main content
Brian Leyland-Jones, MD, Oncology, Sioux Falls, SD

Brian Leyland-Jones MD


Professor, Hematology and Medical Oncology, Emory University School of Medicine

Join to View Full Profile
  • 1000 E 23rd StSte 200Sioux Falls, SD 57105

  • Phone+1 605-322-4673

  • Fax+1 605-322-3020

Dr. Leyland-Jones is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of London Faculty of Medicine
    University of London Faculty of MedicineClass of 1973

Certifications & Licensure

  • SD State Medical License
    SD State Medical License Active through 2027
  • ND State Medical License
    ND State Medical License 2013 - 2026
  • GA State Medical License
    GA State Medical License 2007 - 2025
  • NY State Medical License
    NY State Medical License 1980 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • At Initial Cancer Diagnosis, a Deeply Personalized Assessment
    At Initial Cancer Diagnosis, a Deeply Personalized AssessmentOctober 13th, 2021

Grant Support

  • Towards Identification Of Prognostic Gene Sets In Breast Cancer: The E2197 TrialNational Cancer Institute2010–2011
  • Senior LeadershipNational Cancer Institute2009–2011
  • Program Planning &EvaluationNational Cancer Institute2009–2011
  • Developmental FundsNational Cancer Institute2009–2011
  • Data Safety Monitoring PLANNational Cancer Institute2009–2011
  • Clinical Trials- Protocol SpecificNational Cancer Institute2009–2011
  • Clinical Trials - Protocol Review Monitoring SystemNational Cancer Institute2009–2011
  • Prognostic And Predictive Gene Sets In Her2-Positive Breast Cancer:The Hera TrialNational Cancer Institute2009–2010
  • Emory Winship Cancer Institute Cancer Center Support GrantNational Cancer Institute2009

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: